RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 136 filers reported holding RELAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,011,510 | -28.8% | 714,805 | +6.3% | 0.00% | 0.0% |
| Q2 2023 | $8,445,269 | -21.6% | 672,394 | +2.8% | 0.00% | -33.3% |
| Q1 2023 | $10,769,437 | +10.1% | 653,882 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $9,777,378 | -29.4% | 654,443 | +5.7% | 0.00% | -40.0% |
| Q3 2022 | $13,847,000 | +51.5% | 618,967 | +13.5% | 0.01% | +66.7% |
| Q2 2022 | $9,137,000 | -43.9% | 545,484 | +0.2% | 0.00% | -40.0% |
| Q1 2022 | $16,300,000 | +0.5% | 544,590 | +3.1% | 0.01% | 0.0% |
| Q4 2021 | $16,216,000 | +20.1% | 528,018 | +23.3% | 0.01% | +25.0% |
| Q3 2021 | $13,505,000 | +65.5% | 428,322 | +92.1% | 0.00% | +33.3% |
| Q2 2021 | $8,159,000 | +21.5% | 222,970 | +14.8% | 0.00% | +50.0% |
| Q1 2021 | $6,714,000 | +1.2% | 194,191 | +21.7% | 0.00% | -33.3% |
| Q4 2020 | $6,632,000 | +0.4% | 159,563 | +2.9% | 0.00% | 0.0% |
| Q3 2020 | $6,604,000 | – | 155,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |